The story of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, yielding billions in income, its patent expiration created a wave of knock-off medications, significantly eroding its dominance. While certain firms may try to capitalize on male sexual dysfunction, the existing landscape d… Read More